Cart
sales@molnova.com
Poloxin
CAS No. 321688-88-4
Poloxin ( —— )
Catalog No. M24255 CAS No. 321688-88-4
Poloxin is a non-ATP competitive Polo-like Kinase 1 inhibitor. It targets the polo-box domain (IC50: appr 4.8 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 10MG | 43 | In Stock |
|
| 25MG | 104 | In Stock |
|
| 50MG | 185 | In Stock |
|
| 100MG | 275 | In Stock |
|
| 200MG | 410 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePoloxin
-
NoteResearch use only, not for human use.
-
Brief DescriptionPoloxin is a non-ATP competitive Polo-like Kinase 1 inhibitor. It targets the polo-box domain (IC50: appr 4.8 μM).
-
DescriptionPoloxin is a non-ATP competitive Polo-like Kinase 1 inhibitor. It targets the polo-box domain (IC50: appr 4.8 μM).
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetPLK
-
RecptorPLK1;PLK2;PLK3
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number321688-88-4
-
Formula Weight297.4
-
Molecular FormulaC18H19NO3
-
Purity>98% (HPLC)
-
SolubilityDMSO:14 mg/mL (43.72 mM; Need ultrasonic)
-
SMILESCC(C)C(C(C=C1C)=O)=C/C1=N/OC(c1c(C)cccc1)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Yuan J, et al. Polo-box domain inhibitor poloxin activates the spindle assembly checkpoint and inhibits tumor growth in vivo. Am J Pathol. 2011 Oct;179(4):2091-9.
molnova catalog
related products
-
Ilexsaponin A1
Ilexsaponin A shows protective effects on ischemia-reperfusion-induced myocardial injury through anti-apoptotic pathway.
-
Tebanicline
Tebanicline (ABT-594, Ebanicline) acts as a partial agonist at neuronal nicotinic acetylcholine receptors, binding to both the α3β4 and the α4β2 subtypes.
-
BI-2536
A potent and selective inhibitor of PLK1 with IC50 of 0.83 nM.
